Microbot Medical Inc.

NASDAQ:MBOT

Medical - Instruments & Supplies

Healthcare
$0.98 -2.93%

-$0.06 today

Market cap
$65.73M
Beta
1.04
P/E (TTM)
-8.6
EPS (TTM)
-$0.21
52W Low $1.60High $4.67

Volume 0.87M

Average 1.60M

MBOT Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Microbot Medical Inc.NASDAQ: MBOT

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) growth accelerates

Q1 FY2026 weighted avg shares (diluted) of 67.16M shares rose 294.6% year over year, ahead of the +234.9% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +84.8% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +294.6% holds above the trailing-twelve-month pace of +234.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
67.16M+0.0% QoQ
Last fiscal yearDec 2025
45.79M+192.7% YoY
LTMMar 2026
54.72M+234.9% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+294.6%——
1 year+192.7%——
3-year CAGR+84.8%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
45.79M USD
Year-over-year change
+192.7%
4-year CAGR
+59.3%

Weighted Avg Shares (Diluted) vs competitors

How MBOT compares with its peers on the latest reported figures

  • MBOT's LTM Mar 2026 weighted avg shares (diluted) of 54.72M shares is the 7th highest of the 10 companies compared; the peer median is 74.41M shares.
  • Its year-over-year change of +234.9% is the highest of 10, against a peer median of +8.1%.
  • Over three fiscal years its annual growth of +84.8% compares with a peer median of +3.7%.
MBOT Competitors Peer median
Weighted Avg Shares (Diluted) for MBOT and competitors
Company Period LTM YoY 3-year CAGR
ZTEKZentek Ltd.LTM Mar 2026109.67M +8.1%+2.1%
DCGODocGo Inc.LTM Mar 2026102.83M -1.2%-1.3%
CNTXContext Therapeutics Inc.LTM Mar 202694.36M +30.6%+81.3%
CRDLCardiol Therapeutics Inc.LTM Mar 202694.16M +29.4%+11.6%
OVIDOvid Therapeutics Inc.LTM Mar 202674.41M +4.7%+1.5%
VANIVivani Medical, Inc.LTM Mar 202665.65M +15.7%+17.7%
MBOTMicrobot Medical Inc.LTM Mar 202654.72M +234.9%+84.8%
ORMPOramed Pharmaceuticals Inc.LTM Mar 202642.44M +3.8%+2.8%
RCELAVITA Medical, Inc.LTM Mar 202621.36M -17.9%+3.7%
CLNNClene Inc.LTM Mar 202610.33M +43.6%+44.6%
Peer median (excluding MBOT) 74.41M+8.1%+3.7%

Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00106K91K0
Gross Profit00(106K)(91K)0
Gross Margin—————
Research & Development6.15M7.74M5.72M6.63M6.28M
Selling, General & Admin5.41M5.58M4.13M5M8.25M
Operating Expenses11.36M13.28M9.75M11.53M14.74M
Depreciation & Amortization76K102K106K91K47K
EBITDA(11.24M)(13.34M)(10.63M)(11.35M)(13.1M)
EBITDA Margin—————
Operating Income(11.36M)(13.28M)(9.86M)(11.63M)(14.74M)
Operating Margin—————
Interest Income44K54K228K182K1.29M
Interest Expense00000
Other Income / Expenses44K113K(885K)182K1.6M
Income Before Tax(11.31M)(13.17M)(10.74M)(11.44M)(13.14M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(11.31M)(13.17M)(10.74M)(11.44M)(13.14M)
Net Margin—————
EPS (Basic)(1.59)(1.81)(1.05)(0.73)(0.29)
EPS (Diluted)(1.59)(1.81)(1.05)(0.73)(0.29)
Weighted Avg Shares7.11M7.26M10.2M15.65M45.79M
Weighted Avg Shares (Diluted)7.11M7.26M10.2M15.65M45.79M

Microbot Medical Inc.

NASDAQ:MBOT

Intrinsic Alpha fair value

Locked

Current Price

$0.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.